pharma · Hepatitis C Virus Infection · Chronic Hepatitis B
Gilead Sciences Ireland
Gilead Sciences Ireland UC
Gilead Sciences Ireland trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 333 Lakeside Drive, Foster City, CA 94404, US
- Founded
- 1987
- Employees
- 14,602
- Programs
- 26
- Drugs
- 17
- Patents
- 0
Gilead Sciences Ireland clinical trials
Registry index of 30 ClinicalTrials.gov studies linked to Gilead Sciences Ireland programs — each row shows trial ID, program name, phase, status, and indication.
Gilead Sciences Ireland trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Gilead Sciences Ireland.
-
VOX — Phase 2
Clinical update -
SOF — Phase 2
Clinical update -
SOF — Phase 2
Clinical update -
Sacituzumab Govitecan-hziy — Phase 3
Clinical update -
COBI — Phase 3
Clinical update -
Tenofovir DF — Phase 3
Clinical update -
Presatovir — Phase 2
Clinical update -
AZLI 75 mg two times a day (BID)/ three times a day (TID) — Phase 3
Clinical update